Analysts coverage & consensus
In an effort to increase the transparency towards the financial community, Syensqo Investor Relations collects and shares the most recent analysts’ estimates.
All data are on underlying basis unless stated otherwise. Units: € million / %
| Companies | Lead Analyst | Recommendation | Target Price | ||
| ABN ODDO | Stefano Toffano | Hold | 78 | ||
| Barclays | Katie Richards | Hold | 71 | ||
| Berenberg | Sebastian Bray | Hold | 82 | ||
| Bernstein | James Hooper | Buy | 85 | ||
| BOFA | Matthew Yates | Hold | 85 | ||
| Citi | Ranulf Orr | Suspended | Suspended | ||
| Degroof Petercam | Frank Claassen | Buy | 84 | ||
| Deutsche Bank | Tristan Lamotte | Buy | 93 | ||
| Equita | Massimo Bonisoli | Hold | 82 | ||
| BNP Exane | Laurent Favre | Buy | 95 | ||
| Goldman Sachs | Georgina Fraser | Suspended | Suspended | ||
| ING | Stijn Demeester | Buy | 79 | ||
| JP Morgan | Chetan Udeshi | Buy | 100 | ||
| Jefferies | Marcus Dunford-Castro | Buy | 73 | ||
| KBC | Wim Hoste | Hold | 83 | ||
| Kepler Cheuvreux | Martin Rödiger | Sell | 66 | ||
| Morgan Stanley | Lisa De Neve | Hold | 82 | ||
| Van Lanschot Kempen | Eric Wilmer | Sell | 39 | ||
| Recommendation | Target price | |||
| Buy | 7 | Average | 80 | ||
| Hold | 6 | Max | 100 | ||
| Sell | 2 | Min | 39 | ||
Units: € million / % | LOW | AVERAGE | HIGH | #ESTS |
GROUP SALES | 1,493 | 1,527 | 1,568 | 10 |
| Materials | 915 | 943 | 995 | 10 |
| Specialty Polymers | 599 | 617 | 637 | 7 |
| Composite Materials | 305 | 317 | 328 | 7 |
| Performance & Care | 502 | 509 | 515 | 10 |
| Novecare | 324 | 334 | 342 | 7 |
| Technology Solutions | 170 | 175 | 179 | 7 |
| Other Solutions | 68 | 71 | 77 | 10 |
| Aroma | 68 | 71 | 77 | 10 |
GROSS PROFIT | n.a. | n.a. | n.a. | n.a. |
| Gross Margin | n.a. | n.a. | n.a. | n.a. |
GROUP UNDERLYING EBITDA | 293 | 313 | 329 | 11 |
| Group EBITDA Margin | 19.6% | 20.5% | 21.4% | 10 |
| Materials | 256 | 269 | 279 | 10 |
| EBITDA Margin | 27.5% | 28.5% | 29.5% | 10 |
| Performance & Care | 87 | 90 | 93 | 10 |
| EBITDA Margin | 17.1% | 17.6% | 18.4% | 10 |
| Other Solutions | 5 | 7 | 8 | 10 |
| EBITDA Margin | 7.2% | 9.3% | 10.6% | 10 |
| Corporate | (55) | (51) | (44) | 10 |
CAPEX | n.a. | n.a. | n.a. | n.a. |
OPERATING CASH FLOW | n.a. | n.a. | n.a. | n.a. |
Units: € million / % | LOW | AVERAGE | HIGH | #ESTS |
GROUP SALES | 1,385 | 1,436 | 1,474 | 10 |
| Materials | 839 | 881 | 930 | 10 |
| Specialty Polymers | 516 | 545 | 577 | 7 |
| Composite Materials | 299 | 322 | 340 | 7 |
| Performance & Care | 469 | 481 | 504 | 10 |
| Novecare | 307 | 312 | 325 | 7 |
| Technology Solutions | 160 | 166 | 171 | 7 |
| Other Solutions | 64 | 68 | 72 | 10 |
| Aroma | 64 | 68 | 72 | 10 |
GROSS PROFIT | n.a. | n.a. | n.a. | n.a. |
| Gross Margin | n.a. | n.a. | n.a. | n.a. |
GROUP UNDERLYING EBITDA | 246 | 259 | 276 | 11 |
| Group EBITDA Margin | 16.8% | 18.0% | 19.3% | 10 |
| Materials | 207 | 225 | 245 | 10 |
| EBITDA Margin | 23.1% | 25.5% | 26.9% | 10 |
| Performance & Care | 70 | 77 | 83 | 10 |
| EBITDA Margin | 14.8% | 15.9% | 17.3% | 10 |
| Other Solutions | 5 | 6 | 7 | 10 |
| EBITDA Margin | 6.9% | 8.2% | 10.0% | 10 |
| Corporate | (55) | (48) | (32) | 10 |
CAPEX | n.a. | n.a. | n.a. | n.a. |
OPERATING CASH FLOW | n.a. | n.a. | n.a. | n.a. |
Units: € million / % | LOW | AVERAGE | HIGH | #ESTS |
GROUP SALES | 5,829 | 5,901 | 5,990 | 12 |
| Materials | 3,538 | 3,608 | 3,709 | 11 |
| Specialty Polymers | 2,271 | 2,324 | 2,370 | 8 |
| Composite Materials | 1,218 | 1,265 | 1,304 | 8 |
| Performance & Care | 1,988 | 2,009 | 2,034 | 11 |
| Novecare | 1,315 | 1,332 | 1,346 | 8 |
| Technology Solutions | 656 | 676 | 688 | 8 |
| Other Solutions | 273 | 290 | 302 | 11 |
| Aroma | 273 | 290 | 302 | 11 |
GROSS PROFIT | n.a. | n.a. | n.a. | n.a. |
| Gross Margin | n.a. | n.a. | n.a. | n.a. |
GROUP UNDERLYING EBITDA | 1,111 | 1,135 | 1,150 | 12 |
| Group EBITDA Margin | 19.0% | 19.2% | 19.7% | 12 |
| Materials | 959 | 975 | 996 | 12 |
| EBITDA Margin | 26.6% | 27.0% | 27.3% | 11 |
| Performance & Care | 328 | 340 | 346 | 12 |
| EBITDA Margin | 16.6% | 17.0% | 17.3% | 11 |
| Other Solutions | 20 | 23 | 26 | 12 |
| EBITDA Margin | 7.3% | 8.1% | 8.6% | 11 |
| Corporate | (213) | (201) | (188) | 12 |
CAPEX | n.a. | n.a. | n.a. | n.a. |
OPERATING CASH FLOW | n.a. | n.a. | n.a. | n.a. |